GSK Omjjara (momelotinib) HCP website: mobile vs desktop rendering and certification (AUTH/3909/5/24)

📊

Key facts

⌄

Case number	AUTH/3909/5/24
Company	GSK
Product	Omjjara (momelotinib)
Material type	Promotional webpage on an HCP promotional website (GSKPro)
Allegation	Mobile version not certified; “major changes” between desktop and mobile rendering
Example difference cited	Desktop showed “Get in touch”; mobile showed “Product menu” (with “Get in touch” within the drop-down, per GSK)
Applicable Code year	2021
Clauses considered	2, 5.1, 8.1
Panel decision	No breach of Clauses 8.1, 5.1, or 2
Complaint received	22 May 2024
Case completed	9 May 2025
Appeal	No appeal

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

📋

⌄

An anonymous, contactable complainant (described as a health professional) alleged a GSK promotional webpage for Omjjara (momelotinib) had not been certified for mobile phone use.
The complainant said there were “major changes between the desktop and mobile version” making the mobile version uncertified.
Example cited: on desktop a blue bar showed “Get in touch”; on mobile it appeared as “Product menu”.
GSK stated the page sat within its UK HCP promotional site (GSKPro) and that both desktop and mobile views were reviewed and certified as part of the same job (PM-GB-MML-WCNT-230012 (V1.0)).
GSK explained the mobile “Product menu” was a technical/navigation adaptation for small screens and that “Get in touch” appeared within the drop-down menu; substantive content was the same across devices.

⚖️

⌄

No breach of Clause 8.1 (Requirement to certify promotional material).
No breach of Clause 5.1 (Requirement to maintain high standards at all times).
No breach of Clause 2 (Requirement that activities or materials must not bring discredit upon, or reduce confidence in, the pharmaceutical industry).

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access